Resources for Food and Drug Administration (FDA)

Mixing cholesterol, heart drugs boosts risk of muscle damage: FDA

www.cbc.ca

A drug prescribed for high cholesterol may raise the risk of serious muscle injury in people who also take a medication to control an irregular heart beat, U.S. health officials warned Friday. The advisory expands on a 2002 warning about the risk of rhabdomyolysis, a type of muscle injury that in severe cases can lead to kidney failure or death, when the two types of medicines are combined. The FDA's warning focuses on the cholesterol medication simvastatin, sold in Canada as Zocor, as well as generically.

View the Resource

Share or bookmarklet this web page at: